Affordable Access

deepdyve-link
Publisher Website

A phase II trial of prolonged, continuous infusion of low-dose gemcitabine plus cisplatin in patients with advanced malignant pleural mesothelioma.

Authors
  • Arrieta, Oscar
  • López-Macías, Diego
  • Mendoza-García, Víctor-Osvaldo
  • Bacon-Fonseca, Ludwing
  • Muñoz-Montaño, Wendy
  • Macedo-Pérez, Eleazar-Omar
  • Muñiz-Hernández, Saé
  • Blake-Cerda, Monika
  • Corona-Cruz, José-Francisco
Type
Published Article
Journal
Cancer Chemotherapy and Pharmacology
Publisher
Springer-Verlag
Publication Date
May 01, 2014
Volume
73
Issue
5
Pages
975–982
Identifiers
DOI: 10.1007/s00280-014-2429-5
PMID: 24687408
Source
Medline
License
Unknown

Abstract

Low-dose, prolonged gemcitabine infusion plus cisplatin has acceptable toxicity and high efficacy with improved quality of life, representing an affordable regimen for the low-income population.

Report this publication

Statistics

Seen <100 times